104 related articles for article (PubMed ID: 22027480)
21. [Implications of the arterialization of the sinusoid in its capillarization and in the maintenance of portal hypertension in the cirrhotic patient].
Ceña Lázaro G; Barrao Comps F; Omiste Martínez JL; Ducóns García J; Rojo Puente S; Laquidaín Hergueta M; Bueno Gómez J
Rev Esp Enferm Apar Dig; 1987 Feb; 71(2):111-3. PubMed ID: 3563042
[No Abstract] [Full Text] [Related]
22. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes.
Busk TM; Bendtsen F; Nielsen HJ; Jensen V; Brünner N; Møller S
Scand J Gastroenterol; 2014 Sep; 49(9):1103-10. PubMed ID: 25048331
[TBL] [Abstract][Full Text] [Related]
23. Splenic blood flow in idiopathic portal hypertension in Japan measured by 85Kr clearance method.
Ueda H; Kitani K; Kameda H; Takeda T; Chiba K; Nagatani M; Yamada H; Iio M
Acta Hepatosplenol; 1971; 18(1):28-40. PubMed ID: 5575868
[No Abstract] [Full Text] [Related]
24. Insulin levels and glucose intolerance in patients with cirrhosis and non cirrhotic portal fibrosis.
Vij JC; Gaur SK; Sharma SK; Yadav HS; Kumar N; Anand BS
J Assoc Physicians India; 1987 Jul; 35(7):479-82. PubMed ID: 3323185
[No Abstract] [Full Text] [Related]
25. [Free amino acids in the serum of portal hypertension patients].
Kataeva GA; Eremenko VP
Vestn Khir Im I I Grek; 1971 Apr; 106(4):10-4. PubMed ID: 5565362
[No Abstract] [Full Text] [Related]
26. Specificity of splenic blood flow in liver cirrhosis.
Perisić MD; Culafić DjM; Kerkez M
Rom J Intern Med; 2005; 43(1-2):141-51. PubMed ID: 16739874
[TBL] [Abstract][Full Text] [Related]
27. [Study of central and porto-hepatic hemodynamics before the surgical treatment of patients with liver cirrhosis and portal hypertension].
Eramishantsev AK; Gogichaĭshvili SSh; Lebezev VM; Kitsenko EA; Dolidze MA
Klin Med (Mosk); 1991 Feb; 69(2):81-3. PubMed ID: 1875671
[TBL] [Abstract][Full Text] [Related]
28. [Humoral substances in peripheral and portal veins in cirrhotic patients].
Li SJ; Wang XH; Han JD
Zhonghua Wai Ke Za Zhi; 1988 Jan; 26(1):44-7, 62. PubMed ID: 2904350
[No Abstract] [Full Text] [Related]
29. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
[TBL] [Abstract][Full Text] [Related]
30. Plasma catecholamines in patients with presinusoidal portal hypertension: comparison with cirrhotic patients and nonportal hypertensive subjects.
Gaudin C; Braillon A; Poo JL; Kleber G; Moreau R; Lebrec D
Hepatology; 1991 May; 13(5):913-6. PubMed ID: 2029995
[TBL] [Abstract][Full Text] [Related]
31. Factors participating in the development and mortality of variceal bleeding in portal hypertension--possible effects of the kidney damage and malnutrition.
Lata J; Husová L; Juránková J; Senkyrík M; Díte P; Dastych M; Dastych M; Kroupa R
Hepatogastroenterology; 2006; 53(69):420-5. PubMed ID: 16795985
[TBL] [Abstract][Full Text] [Related]
32. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
Afzelius P; Bazeghi N; Bie P; Bendtsen F; Vestbo J; Møller S
Liver Int; 2011 Oct; 31(9):1381-7. PubMed ID: 21745317
[TBL] [Abstract][Full Text] [Related]
33. [Resorption of ammonium chloride from the intestine under conditions of portal hypertension].
Wagner K; Wirbatz W; Zimmermann HB; Schimmelpfennig W
Z Gesamte Inn Med; 1970 Jun; 25(12):556-8. PubMed ID: 5523403
[No Abstract] [Full Text] [Related]
34. Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis.
Merli M; Di Gregorio V
Aliment Pharmacol Ther; 2018 Jun; 47(11):1536-1537. PubMed ID: 29878421
[No Abstract] [Full Text] [Related]
35. [Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension].
Mazzone O; Randazzo G; Catalano D; Noè I
Clin Ter; 1986 Jul; 118(2):109-14. PubMed ID: 3527539
[No Abstract] [Full Text] [Related]
36. [The ammonia tolerance test in intra- and extrahepatic portal vein block].
Ziegler K
Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):229-32. PubMed ID: 5732402
[No Abstract] [Full Text] [Related]
37. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V
J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
[TBL] [Abstract][Full Text] [Related]
38. Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis-Authors' reply.
Mandorfer M; Reiberger T; Ferlitsch A;
Aliment Pharmacol Ther; 2018 Jun; 47(11):1537-1538. PubMed ID: 29878416
[No Abstract] [Full Text] [Related]
39. Portal vein hemodynamics in cirrhotic patients with portal hypertensive gastropathy: an echo-Doppler study.
Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Shigemori H; Sakaki M; Nakayama M; Tanikawa K; Iwao J
Hepatogastroenterology; 1994 Jun; 41(3):230-4. PubMed ID: 7959544
[TBL] [Abstract][Full Text] [Related]
40. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia.
Ferro D; Quintarelli C; Lattuada A; Leo R; Alessandroni M; Mannucci PM; Violi F
Hepatology; 1996 Jun; 23(6):1377-83. PubMed ID: 8675154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
